apheris
This role focuses on building and scaling federated data networks for drug discovery AI, turning network concepts into production-ready models for top pharmaceutical companies. The position involves end-to-end execution with partners, embedding the Apheris Foundry platform into live drug discovery programs, and serving as a key point of contact for pharma scientists. It requires strong ownership of outcomes and the ability to work effectively with computational chemists, DMPK scientists, and structural biologists.
Apheris builds drug discovery AI delivered via federated data networks to produce superior predictive models. Their software runs locally in customers’ environments so data, queries, and outputs remain secure and in‑house. The platform supports in‑house benchmarking, fine‑tuning for specific targets and chemotypes, and integration via GUI or API. Apheris also enables organizations to join or build federated networks to improve model performance without centralizing sensitive data.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for apheris.
apheris didn’t post a salary, so this is our estimate from similar listings.
19% above the average for this role
Advisor of Computational Peptide Biochemistry
lifelancer
Computational Chemist
General Proximity
Scientific Leader, Integrated Medicinal Chemistry, Computational Chemistry, Cheminformatics and DMPK
Relay Therapeutics
Head of Computational Drug Design, Cambridge, MA
Isomorphic Labs
Post Doctoral Scientist
Gilead Sciences
Sr Scientist, Structural Chemistry
Gilead Sciences